Member Info for Del77

I have noted over the many years i have. been invested , that shortly before news , the SP is often found to be “unloved” by MM’s and priced lower. News comes and the SP , takes off. So perhaps we should be ready for take off on Tuesday 2 April :) GLA LTH D.

Sorry posted twice, pl ignore

Perhaps a matter to consider If SAR is sold and Tim and John secure a consultancy or employment contract , surely the NEDS need to be in post in order to avoid a conflict of interest for Tim and John and “ protect” us share holders, let alone for good goverance compliance. Furthermore and buyer would insist NEDS are in position. From a buyer who may wish to invest c £250m + their own goverance would surely have an issue with dealing with 2 directors

Perhaps a matter to consider If SAR is sold and Tim and John secure a consultancy or employment contract , surely the NEDS would need to be in post in order to avoid a conflict of interest for Tim and John and “ protect” us share holders, let alone for good goverance compliance. Furthermore any buyer would insist NEDS are in position. From a buyers perspective, who may wish to invest c £250m + their own goverance would, surely, IMO , have an issue with dealing with 2 directors and Chairman only without non execs. D.

At the low SP could the directors make an offer to tge share holders at c 50p to take PHD private and delist? Any opinions interestingly received R

Interesting to note equity value in published accounts £103m, market value of capita shares £2,088 m today Too risky for me D.

I think capita is ripe for hedge funds to run shorts against the share price Just look at arriving at the adjusted profit figure of £282.1 m... that is after booking a business exit gain of £309m ! With out the business is loss making . What real assets do capita have to realise apart from intangibles? Be interesting to see how this plays out over the next 12 months , particularly after Carillion , and inter serve and kier issues, who is next? D.

At this level does any one know if their are any competitors who would take proactis out? One of the problems Artemis (II) may face, is that from a goverance perspective, quite often prevents , investments in cos with a MC of less than a specified figure , quite often being £50m, which could lead to more sales of shares in proactis entering the market. D.

I have thought for quite sometime that a buyer of sound or the asset ie tendrara will eventually sign the gsa . If you are ONEE or the ministry of energy would you prefer to sign the gsa with the entity who is going to eventually invest and deliver the gas from the production licence imo for, the benefit of Morrocco ,or company ( sound energy after le)that will shortly not exist...D.

Parkers performance - poor. The issue we face is that many II , before investingin any company, need a cos Market cap to exceed £50m and an income stream to mitigate risk. Having said that hopefully upon receipt of the milestone payment and continued excellent trail/ research updates more interest will be generated, and the share price rerates. This is key. Tim does not like selling himself and is not comfortable in that environment of promoting the co to new II’s Parker on a £1000 per week and need to step forward to promote sareum as many of us expected he would have done by now.The longer this goes on, the only out come is that Sareum gets bought out on the cheap by a major, and us LTHs will not see the value we hope for from our investment. Mr Parker please get out there and promote and raise the profile and awareness of Sareum to potential strategic investors D.

It seems to me MMs are happy to mark the SP lower with the knowledge their is a larger buyer keen to hover up shares with out driving the SP any higher D.

That may be so gunthorpe, but selling now may be far riskier than on previous occasions as the announcement of a milestone payment could drop at any time GLALTH D.

Perhaps new co has been established to purely hold future revenues if the le deal includes future payments in respect of future gas discoveries , and existing sou share holders would receive shares in new co based on their shareholding at le. Sound it self may be taken over and continue to trade under new ownership and be delisted. Only sermising D.

Luckyman , if that is the case , could we assume we will know the outcome of LE and TE10 ,good or bad ,before he leaves..... GLA LTH D.

In a RNS dated 23 Jan 2018 , it was confirmed than JP would remain in his role for the next 12 to 18 months D.

Thanks Thoth2 Interesting sierra closed after hours at usd 1.80 D.

Interesting we have not received notice of interim accounts being published. Compared to the previous 3 years the accounts woukd have been published or at least notice given of a date to receive the published accounts. Interestingly the previous set of year end accounts were earlier than normal and appeared rushed out as were still subject to final audit. I wonder why their is a small delay? Hopefully we will receive an RNS stating that interim accounts will be published in the next 4 weeks. D.

In my opinion the two 2.6m transactions were a sell and then an immediate buy back to put in an ISA . This is supported by no fall in the share price after the transaction went through D.

Joe i am with you. If the intention really is to have a drink with no presentation ... i think we need toread between the lines. I have not heard of a CEO inviting shareholders for a pint with out a structured meeting / presentation. .. perhaps this is the first and (last ?) time..but what do i know?.GLA LTH D.

I understand that the CRT Pioneer fund is the most successful body in terms of funds raised from its own IPR when compared with all the uk research councils in the UK. As such i am sure CRT will employ in house legal experts to both create ip agreements, and “ manage and monitor” those agreements. I am therefore absolutely sure they will be closely monitoring our agreement with Sierra Therapeutics , with specific reference to the next milestone payment. Looking at the big picture the agreement was signed i recall in Sept 2016, and with the progress reported since by Sierra Therapeutics our next milestone payment in my opinion can not be far away, with almost certainly in 2019. I also recall a director of Sierra Therapeutics purchased c 66000 Sierra shares around 8 + weeks ago, so perhaps we can expect news around April AIMHO GLALTH D.